XML 50 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Data Unaudited (Tables)
12 Months Ended
Dec. 31, 2013
Quarterly Financial Data Abstract  
Schedule of Quarterly Financial Information [Table Text Block]
  2013 2012
  Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
                         
  (In thousands, except per share data)
                         
Revenues $ 259,043 $ 268,099 $ 267,631 $ 284,570 $ 227,567 $ 228,955 $ 223,885 $ 242,775
Earnings from continuing operations                        
 before income taxes   74,496   78,398   73,989   81,644   66,110   66,611   63,211   67,854
Net earnings from continuing operations   62,203   65,640   62,562   68,368   55,349   55,541   53,148   57,384
Net earnings (loss) from                        
 discontinued operations (1)  70   196   (295)   2,800   (410)   4   617   2,010
Net earnings   62,273   65,836   62,267   71,168   54,939   55,545   53,765   59,394
                         
Net earnings (loss) attributable to                        
 AmSurg Corp. common shareholders:                       
 Continuing   17,785   18,489   17,056   19,323   15,488   15,939   15,196   15,612
 Discontinued   26   74   (285)   235   (712)   (403)   241   1,202
                         
 Net earnings $ 17,811 $ 18,563 $ 16,771 $ 19,558 $ 14,776 $ 15,536 $ 15,437 $ 16,814
                         
                         
Diluted net earnings from                        
 continuing operations per common share $ 0.56 $ 0.58 $ 0.53 $ 0.60 $ 0.49 $ 0.50 $ 0.48 $ 0.49
                         
Diluted net earnings per common share $ 0.56 $ 0.58 $ 0.52 $ 0.61 $ 0.47 $ 0.49 $ 0.49 $ 0.53